Ophthalmic Drugs Market Size, Share & Trends Analysis Report By Drug Class (Steroidal drugs, Anti-VEGF Agents), By Disease, By Dosage Form, By Route of Administration, By Product Type, By Drug Type, By Region, And Segment Forecasts, 2025 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Drug class
                       1.2.2. Disease
                       1.2.3. Route of administration
                       1.2.4. Dosage type
                       1.2.5. Product type
                       1.2.6. Drug type
                       1.2.7. Regional scope
                       1.2.8. Estimates and forecasts timeline.
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased database
                       1.4.2. GVR’s internal database
                       1.4.3. Secondary sources
                       1.4.4. Primary research
                       1.4.5. Details of primary research
                   1.5. Information or Data Analysis
                       1.5.1. Data analysis models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                       1.7.1. Commodity flow analysis (Model 1)
                       1.7.2. Approach 1: Commodity flow approach
                       1.7.3. Volume price analysis (Model 2)
                       1.7.4. Approach 2: Volume price analysis
                   1.8. List of Secondary Sources
                   1.9. List of Primary Sources
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Drug class outlook
                       2.2.2. Disease outlook
                       2.2.3. Route of administration outlook
                       2.2.4. Dosage type outlook
                       2.2.5. Product type outlook
                       2.2.6. Drug type outlook
                       2.2.7. Regional outlook
                   2.3. Competitive Insights
Chapter 3. Ophthalmic Drugs Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook.
                   3.2. Market Dynamics
                       3.2.1. Market driver analysis
                           3.2.1.1. Increasing diseases prevalence
                           3.2.1.2. String development pipeline
                           3.2.1.3. Advancements in drug delivery
                       3.2.2. Market restraint analysis
                           3.2.2.1. Patent expiry of blockbuster drugs
                   3.3. Ophthalmic Drugs Market Analysis Tools
                       3.3.1. Industry Analysis – Porter’s
                       3.3.2. PESTEL Analysis
Chapter 4. Ophthalmic Drugs Market: Drug Class Estimates & Trend Analysis
                   4.1. Segment Dashboard
                   4.2. Ophthalmic Drugs Market: Drug Class Movement Analysis
                   4.3. Ophthalmic Drugs Market Size & Trend Analysis, by Drug Class, 2018 to 2030 (USD Million)
                   4.4. Anti-Allergy
                       4.4.1. Anti-Allergy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                   4.5. Anti-VEGF agents
                       4.5.1. Anti-VEGF agents market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                   4.6. Anti-inflammatory
                       4.6.1. Anti-inflammatory market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                       4.6.2. Non-steroidal Drugs
                           4.6.2.1. Non-steroidal Drugs market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                       4.6.3. Steroids
                           4.6.3.1. Steroids market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                   4.7. Anti-glaucoma
                       4.7.1. Anti-glaucoma market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                   4.8. Gene & Cell Therapy
                       4.8.1. Gene & Cell Therapy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                   4.9. Others
                       4.9.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. Ophthalmic Drugs Market: Disease Estimates & Trend Analysis
                   5.1. Segment Dashboard
                   5.2. Ophthalmic Drugs Market: Disease Movement Analysis
                   5.3. Ophthalmic Drugs Market Size & Trend Analysis, by Disease, 2018 to 2030 (USD Million)
                   5.4. Dry eye
                       5.4.1. Dry eye market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.4.1.1. Gels
                               5.4.1.1.1. Gels market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.4.1.2. Eye solutions & suspensions
                               5.4.1.2.1. Eye solutions & suspensions market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.4.1.3. Capsules & tablets
                               5.4.1.3.1. Capsules & tablets market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.4.1.4. Eye drops
                               5.4.1.4.1. Eye drops market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.4.1.5. Ointments
                               5.4.1.5.1. Ointments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                   5.5. Allergies
                       5.5.1. Allergies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.5.1.1. Gels
                               5.5.1.1.1. Gels market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.5.1.2. Eye solutions & suspensions
                               5.5.1.2.1. Eye solutions & suspensions market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.5.1.3. Capsules & tablets
                               5.5.1.3.1. Capsules & tablets market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.5.1.4. Eye drops
                               5.5.1.4.1. Eye drops market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.5.1.5. Ointments
                               5.5.1.5.1. Ointments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                   5.6. Glaucoma
                       5.6.1. Glaucoma market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.6.1.1. Gels
                               5.6.1.1.1. Gels market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.6.1.2. Eye solutions & suspensions
                               5.6.1.2.1. Eye solutions & suspensions market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.6.1.3. Capsules & tablets
                               5.6.1.3.1. Capsules & tablets market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.6.1.4. Eye drops
                               5.6.1.4.1. Eye drops market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.6.1.5. Ointments
                               5.6.1.5.1. Ointments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                   5.7. Infection
                       5.7.1. Infection market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.7.1.1. Gels
                               5.7.1.1.1. Gels market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.7.1.2. Eye solutions & suspensions
                               5.7.1.2.1. Eye solutions & suspensions market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.7.1.3. Capsules & tablets
                               5.7.1.3.1. Capsules & tablets market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.7.1.4. Eye drops
                               5.7.1.4.1. Eye drops market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.7.1.5. Ointments
                               5.7.1.5.1. Ointments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                   5.8. Retinal Disorders
                       5.8.1. Retinal disorders market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                       5.8.2. By Dosage Type
                           5.8.2.1. Gels
                               5.8.2.1.1. Gels market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.8.2.2. Eye solutions & suspensions
                               5.8.2.2.1. Eye solutions & suspensions market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.8.2.3. Capsules & tablets
                               5.8.2.3.1. Capsules & tablets market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.8.2.4. Eye drops
                               5.8.2.4.1. Eye drops market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.8.2.5. Ointments
                               5.8.2.5.1. Ointments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                       5.8.3. By Type
                           5.8.3.1. Macular degeneration
                               5.8.3.1.1. Macular degeneration market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.8.3.2. Diabetic retinopathy
                               5.8.3.2.1. Diabetic retinopathy market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.8.3.3. Others
                               5.8.3.3.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                   5.9. Uveitis
                       5.9.1. Uveitis market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.9.1.1. Gels
                               5.9.1.1.1. Gels market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.9.1.2. Eye solutions & suspensions
                               5.9.1.2.1. Eye solutions & suspensions market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.9.1.3. Capsules & tablets
                               5.9.1.3.1. Capsules & tablets market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.9.1.4. Eye drops
                               5.9.1.4.1. Eye drops market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.9.1.5. Ointments
                               5.9.1.5.1. Ointments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                   5.10. Others
                       5.10.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.10.1.1. Gels
                               5.10.1.1.1. Gels market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.10.1.2. Eye solutions & suspensions
                               5.10.1.2.1. Eye solutions & suspensions market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.10.1.3. Capsules & tablets
                               5.10.1.3.1. Capsules & tablets market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.10.1.4. Eye drops
                               5.10.1.4.1. Eye drops market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           5.10.1.5. Ointments
                               5.10.1.5.1. Ointments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. Ophthalmic Drugs Market: Route of Administration Estimates & Trend Analysis
                   6.1. Segment Dashboard
                   6.2. Ophthalmic Drugs Market: Route of Administration Movement Analysis
                   6.3. Ophthalmic Drugs Market Size & Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
                   6.4. Topical
                       6.4.1. Topical market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                   6.5. Local Ocular
                       6.5.1. Local ocular market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           6.5.1.1. Subconjunctival
                               6.5.1.1.1. Subconjunctival market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           6.5.1.2. Intravitreal
                               6.5.1.2.1. Intravitreal market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           6.5.1.3. Retrobulbar
                               6.5.1.3.1. Retrobulbar market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                           6.5.1.4. Intracameral
                               6.5.1.4.1. Intracameral market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                   6.6. Sytemic
                       6.6.1. Sytemic market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Ophthalmic Drugs Market: Dosage Type Estimates & Trend Analysis
                   7.1. Segment Dashboard
                   7.2. Ophthalmic Drugs Market: Dosage Type Movement Analysis
                   7.3. Ophthalmic Drugs Market Size & Trend Analysis, by Dosage Type, 2018 to 2030 (USD Million)
                   7.4. Gels
                       7.4.1. Gels market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                   7.5. Eye solutions & suspensions
                       7.5.1. Eye solutions & suspensions market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                   7.6. Capsules & Tablets
                       7.6.1. Capsules & tablets market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                   7.7. Eye drops
                       7.7.1. Eye drops market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                   7.8. Ointments
                       7.8.1. Ointments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8. Ophthalmic Drugs Market: Product Type Estimates & Trend Analysis
                   8.1. Segment Dashboard
                   8.2. Ophthalmic Drugs Market: Product Type Movement Analysis
                   8.3. Ophthalmic Drugs Market Size & Trend Analysis, by Product Type, 2018 to 2030 (USD Million)
                   8.4. OTC
                       8.4.1. OTC market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                   8.5. Prescription Drugs
                       8.5.1. Prescription drugs market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 9. Ophthalmic Drugs Market: Drug Type Estimates & Trend Analysis
                   9.1. Segment Dashboard
                   9.2. Ophthalmic Drugs Market: Drug Type Movement Analysis
                   9.3. Ophthalmic Drugs Market Size & Trend Analysis, by Drug Type, 2018 to 2030 (USD Million)
                   9.4. Branded Drugs
                       9.4.1. Branded drugs market revenue estimates and forecasts, 2018 - 2030 (USD Million)
                   9.5. Generic Drugs
                       9.5.1. Generic drugs market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 10. Ophthalmic Drugs Market: Regional Estimates & Trend Analysis
                   10.1. Regional Market Share Analysis, 2023 & 2030
                   10.2. Regional Market Dashboard
                   10.3. Global Regional Market Snapshot
                   10.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
                   10.5. North America
                       10.5.1. U.S.
                           10.5.1.1. Key country dynamics
                           10.5.1.2. Regulatory framework/Reimbursement
                           10.5.1.3. Competitive scenario
                           10.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
                       10.5.2. Canada
                           10.5.2.1. Key country dynamics
                           10.5.2.2. Regulatory framework/Reimbursement
                           10.5.2.3. Competitive scenario
                           10.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
                       10.5.3. Mexico
                           10.5.3.1. Key country dynamics
                           10.5.3.2. Regulatory framework/Reimbursement
                           10.5.3.3. Competitive scenario
                           10.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
                   10.6. Europe
                       10.6.1. UK
                           10.6.1.1. Key country dynamics
                           10.6.1.2. Regulatory framework/Reimbursement
                           10.6.1.3. Competitive scenario
                           10.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
                       10.6.2. Germany
                           10.6.2.1. Key country dynamics
                           10.6.2.2. Regulatory framework/Reimbursement
                           10.6.2.3. Competitive scenario
                           10.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
                       10.6.3. France
                           10.6.3.1. Key country dynamics
                           10.6.3.2. Regulatory framework/Reimbursement
                           10.6.3.3. Competitive scenario
                           10.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
                       10.6.4. Italy
                           10.6.4.1. Key country dynamics
                           10.6.4.2. Regulatory framework/Reimbursement
                           10.6.4.3. Competitive scenario
                           10.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
                       10.6.5. Spain
                           10.6.5.1. Key country dynamics
                           10.6.5.2. Regulatory framework/Reimbursement
                           10.6.5.3. Competitive scenario
                           10.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
                       10.6.6. Norway
                           10.6.6.1. Key country dynamics
                           10.6.6.2. Regulatory framework/Reimbursement
                           10.6.6.3. Competitive scenario
                           10.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
                       10.6.7. Sweden
                           10.6.7.1. Key country dynamics
                           10.6.7.2. Regulatory framework/Reimbursement
                           10.6.7.3. Competitive scenario
                           10.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
                       10.6.8. Denmark
                           10.6.8.1. Key country dynamics
                           10.6.8.2. Regulatory framework/Reimbursement
                           10.6.8.3. Competitive scenario
                           10.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
                   10.7. Asia Pacific
                       10.7.1. Japan
                           10.7.1.1. Key country dynamics
                           10.7.1.2. Regulatory framework/Reimbursement
                           10.7.1.3. Competitive scenario
                           10.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
                       10.7.2. China
                           10.7.2.1. Key country dynamics
                           10.7.2.2. Regulatory framework/Reimbursement
                           10.7.2.3. Competitive scenario
                           10.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
                       10.7.3. India
                           10.7.3.1. Key country dynamics
                           10.7.3.2. Regulatory framework/Reimbursement
                           10.7.3.3. Competitive scenario
                           10.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
                       10.7.4. Australia
                           10.7.4.1. Key country dynamics
                           10.7.4.2. Regulatory framework/Reimbursement
                           10.7.4.3. Competitive scenario
                           10.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
                       10.7.5. South Korea
                           10.7.5.1. Key country dynamics
                           10.7.5.2. Regulatory framework/Reimbursement
                           10.7.5.3. Competitive scenario
                           10.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
                       10.7.6. Thailand
                           10.7.6.1. Key country dynamics
                           10.7.6.2. Regulatory framework/Reimbursement
                           10.7.6.3. Competitive scenario
                           10.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
                   10.8. Latin America
                       10.8.1. Brazil
                           10.8.1.1. Key country dynamics
                           10.8.1.2. Regulatory framework/Reimbursement
                           10.8.1.3. Competitive scenario
                           10.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
                       10.8.2. Argentina
                           10.8.2.1. Key country dynamics
                           10.8.2.2. Regulatory framework/Reimbursement
                           10.8.2.3. Competitive scenario
                           10.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
                   10.9. MEA
                       10.9.1. South Africa
                           10.9.1.1. Key country dynamics
                           10.9.1.2. Regulatory framework/Reimbursement
                           10.9.1.3. Competitive scenario
                           10.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
                       10.9.2. Saudi Arabia
                           10.9.2.1. Key country dynamics
                           10.9.2.2. Regulatory framework/Reimbursement
                           10.9.2.3. Competitive scenario
                           10.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
                       10.9.3. UAE
                           10.9.3.1. Key country dynamics
                           10.9.3.2. Regulatory framework/Reimbursement
                           10.9.3.3. Competitive scenario
                           10.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
                       10.9.4. Kuwait
                           10.9.4.1. Key country dynamics
                           10.9.4.2. Regulatory framework
                           10.9.4.3. Competitive scenario
                           10.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 11. Competitive Landscape
                   11.1. Recent Developments & Impact Analysis, By Key Market Participants
                   11.2. Company/Competition Categorization
                   11.3. Vendor Landscape
                       11.3.1. List of key distributors and channel partners
                       11.3.2. Key customers
                       11.3.3. Key company market share analysis, 2023
                       11.3.4. Alcon
                           11.3.4.1. Company overview
                           11.3.4.2. Financial performance
                           11.3.4.3. Services benchmarking
                           11.3.4.4. Strategic initiatives
                       11.3.5. Novartis AG
                           11.3.5.1. Company overview
                           11.3.5.2. Financial performance
                           11.3.5.3. Services benchmarking
                           11.3.5.4. Strategic initiatives
                       11.3.6. Bausch Health Companies, Inc.
                           11.3.6.1. Company overview
                           11.3.6.2. Financial performance
                           11.3.6.3. Services benchmarking
                           11.3.6.4. Strategic initiatives
                       11.3.7. Merck & Co., Inc.
                           11.3.7.1. Company overview
                           11.3.7.2. Financial performance
                           11.3.7.3. Services benchmarking
                           11.3.7.4. Strategic initiatives
                       11.3.8. Regeneron Pharmaceuticals, Inc.
                           11.3.8.1. Company overview
                           11.3.8.2. Financial performance
                           11.3.8.3. Services benchmarking
                           11.3.8.4. Strategic initiatives
                       11.3.9. Coherus BioSciences, Inc.
                           11.3.9.1. Company overview
                           11.3.9.2. Financial performance
                           11.3.9.3. Services benchmarking
                           11.3.9.4. Strategic initiatives
                       11.3.10. AbbVie, Inc. (Allergan)
                           11.3.10.1. Company overview
                           11.3.10.2. Financial performance
                           11.3.10.3. Services benchmarking
                           11.3.10.4. Strategic initiatives
                       11.3.11. Pfizer, Inc.
                           11.3.11.1. Company overview
                           11.3.11.2. Financial performance
                           11.3.11.3. Services benchmarking
                           11.3.11.4. Strategic initiatives
                       11.3.12. Bayer AG
                           11.3.12.1. Company overview
                           11.3.12.2. Financial performance
                           11.3.12.3. Services benchmarking
                           11.3.12.4. Strategic initiatives
                       11.3.13. Santen Pharmaceutical Co., Ltd.
                           11.3.13.1. Company overview
                           11.3.13.2. Financial performance
                           11.3.13.3. Services benchmarking
                           11.3.13.4. Strategic initiatives
                       11.3.14. Roche (Genentech, Inc.)
                           11.3.14.1. Company overview
                           11.3.14.2. Financial performance
                           11.3.14.3. Services benchmarking
                           11.3.14.4. Strategic initiatives
                       11.3.15. Nicox
                           11.3.15.1. Company overview
                           11.3.15.2. Financial performance
                           11.3.15.3. Services benchmarking
                           11.3.15.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 North America ophthalmic drugs market, by region, 2018 - 2030 (USD Million)
Table 3 North America ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 4 North America ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 5 North America ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 6 North America ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 7 North America ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 8 North America ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 9 U.S. ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 10 U.S. ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 11 U.S. ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 12 U.S. ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 13 U.S. ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 14 U.S. ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 15 Canada ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 16 Canada ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 17 Canada ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 18 Canada ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 19 Canada ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 20 Canada ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 21 Mexico ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 22 Mexico ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 23 Mexico ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 24 Mexico ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 25 Mexico ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 26 Mexico ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 27 Europe ophthalmic drugs market, by region, 2018 - 2030 (USD Million)
Table 28 Europe ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 29 Europe ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 30 Europe ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 31 Europe ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 32 Europe ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 33 Europe ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 34 UK ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 35 UK ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 36 UK ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 37 UK ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 38 UK ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 39 UK ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 40 Germany ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 41 Germany ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 42 Germany ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 43 Germany ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 44 Germany ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 45 Germany ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 46 France ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 47 France ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 48 France ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 49 France ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 50 France ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 51 France ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 52 Italy ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 53 Italy ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 54 Italy ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 55 Italy ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 56 Italy ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 57 Italy ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 58 Spain ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 59 Spain ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 60 Spain ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 61 Spain ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 62 Spain ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 63 Spain ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 64 Denmark ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 65 Denmark ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 66 Denmark ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 67 Denmark ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 68 Denmark ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 69 Denmark ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 70 Sweden ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 71 Sweden ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 72 Sweden ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 73 Sweden ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 74 Sweden ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 75 Sweden ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 76 Norway ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 77 Norway ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 78 Norway ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 79 Norway ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 80 Norway ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 81 Norway ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 82 Asia Pacific ophthalmic drugs market, by region, 2018 - 2030 (USD Million)
Table 83 Asia Pacific ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 84 Asia Pacific ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 85 Asia Pacific ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 86 Asia Pacific ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 87 Asia Pacific ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 88 China ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 89 China ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 90 China ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 91 China ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 92 China ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 93 China ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 94 Japan ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 95 Japan ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 96 Japan ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 97 Japan ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 98 Japan ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 99 Japan ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 100 India ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 101 India ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 102 India ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 103 India ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 104 India ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 105 India ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 106 Australia ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 107 Australia ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 108 Australia ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 109 Australia ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 110 Australia ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 111 Australia ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 112 South Korea ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 113 South Korea ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 114 South Korea ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 115 South Korea ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 116 South Korea ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 117 South Korea ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 118 Thailand ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 119 Thailand ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 120 Thailand ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 121 Thailand ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 122 Thailand ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 123 Thailand ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 124 Latin America ophthalmic drugs market, by region, 2018 - 2030 (USD Million)
Table 125 Latin America ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 126 Latin America ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 127 Latin America ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 128 Latin America ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 129 Latin America ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 130 Latin America ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 131 Brazil ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 132 Brazil ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 133 Brazil ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 134 Brazil ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 135 Brazil ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 136 Brazil ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 137 Argentina ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 138 Argentina ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 139 Argentina ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 140 Argentina ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 141 Argentina ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 142 Argentina ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 143 MEA ophthalmic drugs market, by region, 2018 - 2030 (USD Million)
Table 144 MEA ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 145 MEA ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 146 MEA ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 147 MEA ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 148 MEA ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 149 MEA ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 150 South Africa ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 151 South Africa ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 152 South Africa ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 153 South Africa ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 154 South Africa ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 155 South Africa ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 156 Saudi Arabia ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 157 Saudi Arabia ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 158 Saudi Arabia ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 159 Saudi Arabia ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 160 Saudi Arabia ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 161 Saudi Arabia ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 162 UAE ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 163 UAE ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 164 UAE ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 165 UAE ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 166 UAE ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 167 UAE ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)
Table 168 Kuwait ophthalmic drugs market, by drug class, 2018 - 2030 (USD Million)
Table 169 Kuwait ophthalmic drugs market, by disease, 2018 - 2030 (USD Million)
Table 170 Kuwait ophthalmic drugs market, by route of administration, 2018 - 2030 (USD Million)
Table 171 Kuwait ophthalmic drugs market, by dosage type, 2018 - 2030 (USD Million)
Table 172 Kuwait ophthalmic drugs market, by product type, 2018 - 2030 (USD Million)
Table 173 Kuwait ophthalmic drugs market, by drug type, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Ophthalmic drugs market: market outlook
Fig. 14 Ophthalmic drugs competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Ophthalmic drugs market driver impact
Fig. 20 Ophthalmic drugs market restraint impact
Fig. 21 Ophthalmic drugs market strategic initiatives analysis
Fig. 22 Ophthalmic drugs market: Drug class movement analysis
Fig. 23 Ophthalmic drugs market: Drug class outlook and key takeaways
Fig. 24 Anti-Allergy market estimates and forecasts, 2018 - 2030
Fig. 25 Anti-VEGF agents market estimates and forecasts, 2018 - 2030
Fig. 26 Anti-inflammatory market estimates and forecasts, 2018 - 2030
Fig. 27 Non steroidal drugs market estimates and forecasts, 2018 - 2030
Fig. 28 Steroidal drugs market estimates and forecasts, 2018 - 2030
Fig. 29 Anti glaucoma market estimates and forecasts, 2018 - 2030
Fig. 30 Gene & cell therapy market estimates and forecasts, 2018 - 2030
Fig. 31 Others market estimates and forecasts, 2018 - 2030
Fig. 32 Ophthalmic drugs market: Disease movement analysis
Fig. 33 Ophthalmic drugs market: Disease outlook and key takeaways
Fig. 34 Dry eye market estimates and forecasts, 2018 - 2030
Fig. 35 Gels market estimates and forecasts, 2018 - 2030
Fig. 36 Eye solutions & suspensions market estimates and forecasts, 2018 - 2030
Fig. 37 Capsules & tablets market estimates and forecasts, 2018 - 2030
Fig. 38 Eye drops market estimates and forecasts, 2018 - 2030
Fig. 39 Ointments market estimates and forecasts, 2018 - 2030
Fig. 40 Allergies market estimates and forecasts, 2018 - 2030
Fig. 41 Gels market estimates and forecasts, 2018 - 2030
Fig. 42 Eye solutions & suspensions market estimates and forecasts, 2018 - 2030
Fig. 43 Capsules & tablets market estimates and forecasts, 2018 - 2030
Fig. 44 Eye drops market estimates and forecasts, 2018 - 2030
Fig. 45 Ointments market estimates and forecasts, 2018 - 2030
Fig. 46 Glaucoma market estimates and forecasts, 2018 - 2030
Fig. 47 Gels market estimates and forecasts, 2018 - 2030
Fig. 48 Eye solutions & suspensions market estimates and forecasts, 2018 - 2030
Fig. 49 Capsules & tablets market estimates and forecasts, 2018 - 2030
Fig. 50 Eye drops market estimates and forecasts, 2018 - 2030
Fig. 51 Ointments market estimates and forecasts, 2018 - 2030
Fig. 52 Infection market estimates and forecasts, 2018 - 2030
Fig. 53 Gels market estimates and forecasts, 2018 - 2030
Fig. 54 Eye solutions & suspensions market estimates and forecasts, 2018 - 2030
Fig. 55 Capsules & tablets market estimates and forecasts, 2018 - 2030
Fig. 56 Eye drops market estimates and forecasts, 2018 - 2030
Fig. 57 Ointments market estimates and forecasts, 2018 - 2030
Fig. 58 Retinal disorders market estimates and forecasts, 2018 - 2030
Fig. 59 By type market estimates and forecasts, 2018 - 2030
Fig. 60 Macular degeneration market estimates and forecasts, 2018 - 2030
Fig. 61 Diabetic retinopathy market estimates and forecasts, 2018 - 2030
Fig. 62 Others market estimates and forecasts, 2018 - 2030
Fig. 63 By dosage type market estimates and forecasts, 2018 - 2030
Fig. 64 Gels market estimates and forecasts, 2018 - 2030
Fig. 65 Eye solutions & suspensions market estimates and forecasts, 2018 - 2030
Fig. 66 Capsules & tablets market estimates and forecasts, 2018 - 2030
Fig. 67 Eye drops market estimates and forecasts, 2018 - 2030
Fig. 68 Ointments market estimates and forecasts, 2018 - 2030
Fig. 69 Uveitis market estimates and forecasts, 2018 - 2030
Fig. 70 Gels market estimates and forecasts, 2018 - 2030
Fig. 71 Eye solutions & suspensions market estimates and forecasts, 2018 - 2030
Fig. 72 Capsules & tablets market estimates and forecasts, 2018 - 2030
Fig. 73 Eye drops market estimates and forecasts, 2018 - 2030
Fig. 74 Ointments market estimates and forecasts, 2018 - 2030
Fig. 75 Others market estimates and forecasts, 2018 - 2030
Fig. 76 Gels market estimates and forecasts, 2018 - 2030
Fig. 77 Eye solutions & suspensions market estimates and forecasts, 2018 - 2030
Fig. 78 Capsules & tablets market estimates and forecasts, 2018 - 2030
Fig. 79 Eye drops market estimates and forecasts, 2018 - 2030
Fig. 80 Ointments market estimates and forecasts, 2018 - 2030
Fig. 81 Ophthalmic drugs market: Dosage type movement analysis
Fig. 82 Ophthalmic drugs market: Dosage type outlook and key takeaways
Fig. 83 Gels market estimates and forecasts, 2018 - 2030
Fig. 84 Eye solutions & suspensions market estimates and forecasts, 2018 - 2030
Fig. 85 Capsules & tablets market estimates and forecasts, 2018 - 2030
Fig. 86 Eye drops market estimates and forecasts, 2018 - 2030
Fig. 87 Ointments market estimates and forecasts, 2018 - 2030
Fig. 88 Ophthalmic drugs market: Route of administration movement analysis
Fig. 89 Ophthalmic drugs market: Route of administration outlook and key takeaways
Fig. 90 Topical market estimates and forecasts, 2018 - 2030
Fig. 91 Local Ocular market estimates and forecasts, 2018 - 2030
Fig. 92 Subconjunctival market estimates and forecasts, 2018 - 2030
Fig. 93 Intravitreal market estimates and forecasts, 2018 - 2030
Fig. 94 Retrobulbar market estimates and forecasts, 2018 - 2030
Fig. 95 Intracameral market estimates and forecasts, 2018 - 2030
Fig. 96 Sytemic market estimates and forecasts, 2018 - 2030
Fig. 97 Ophthalmic drugs market: Product type movement analysis
Fig. 98 Ophthalmic drugs market: Product type outlook and key takeaways
Fig. 99 OTC market estimates and forecasts, 2018 - 2030
Fig. 100 Prescription drugs market estimates and forecasts, 2018 - 2030
Fig. 101 Ophthalmic drugs market: Drug type movement analysis
Fig. 102 Ophthalmic drugs market: Drug type outlook and key takeaways
Fig. 103 Branded drugs market estimates and forecasts, 2018 - 2030
Fig. 104 Generic drugs market estimates and forecasts, 2018 - 2030
Fig. 105 Global ophthalmic drugs market: Regional movement analysis
Fig. 106 Global ophthalmic drugs market: Regional outlook and key takeaways
Fig. 107 Global ophthalmic drugs market share and leading players
Fig. 108 North America market share and leading players
Fig. 109 Europe market share and leading players
Fig. 110 Asia Pacific market share and leading players
Fig. 111 Latin America market share and leading players
Fig. 112 Middle East & Africa market share and leading players
Fig. 113 North America, by country
Fig. 114 North America
Fig. 115 North America market estimates and forecasts, 2018 - 2030
Fig. 116 U.S. key country dynamics
Fig. 117 U.S. market estimates and forecasts, 2018 - 2030
Fig. 118 Canada country dynamics
Fig. 119 Canada market estimates and forecasts, 2018 - 2030
Fig. 120 Mexico country dynamics
Fig. 121 Mexico market estimates and forecasts, 2018 - 2030
Fig. 122 Europe
Fig. 123 Europe market estimates and forecasts, 2018 - 2030
Fig. 124 UK country dynamics
Fig. 125 UK market estimates and forecasts, 2018 - 2030
Fig. 126 Germany
Fig. 127 Germany market estimates and forecasts, 2018 - 2030
Fig. 128 France country dynamics
Fig. 129 France market estimates and forecasts, 2018 - 2030
Fig. 130 Italy country dynamics
Fig. 131 Italy market estimates and forecasts, 2018 - 2030
Fig. 132 Spain country dynamics
Fig. 133 Spain market estimates and forecasts, 2018 - 2030
Fig. 134 Denmark country dynamics
Fig. 135 Denmark market estimates and forecasts, 2018 - 2030
Fig. 136 Sweden country dynamics
Fig. 137 Sweden market estimates and forecasts, 2018 - 2030
Fig. 138 Norway country dynamics
Fig. 139 Norway market estimates and forecasts, 2018 - 2030
Fig. 140 Asia Pacific
Fig. 141 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 142 China country dynamics
Fig. 143 China market estimates and forecasts, 2018 - 2030
Fig. 144 Japan country dynamics
Fig. 145 Japan market estimates and forecasts, 2018 - 2030
Fig. 146 India country dynamics
Fig. 147 India market estimates and forecasts, 2018 - 2030
Fig. 148 Thailand country dynamics
Fig. 149 Thailand market estimates and forecasts, 2018 - 2030
Fig. 150 South Korea country dynamics
Fig. 151 South Korea market estimates and forecasts, 2018 - 2030
Fig. 152 Australia country dynamics
Fig. 153 Australia market estimates and forecasts, 2018 - 2030
Fig. 154 Latin America
Fig. 155 Latin America market estimates and forecasts, 2018 - 2030
Fig. 156 Brazil country dynamics
Fig. 157 Brazil market estimates and forecasts, 2018 - 2030
Fig. 158 Argentina country dynamics
Fig. 159 Argentina market estimates and forecasts, 2018 - 2030
Fig. 160 Middle East and Africa
Fig. 161 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 162 South Africa country dynamics
Fig. 163 South Africa market estimates and forecasts, 2018 - 2030
Fig. 164 Saudi Arabia country dynamics
Fig. 165 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 166 UAE country dynamics
Fig. 167 UAE market estimates and forecasts, 2018 - 2030
Fig. 168 Kuwait country dynamics
Fig. 169 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 170 Market share of key market players - Syndromic multiplex diagnostics market, 2023
Fig. 171 Company Categorization